Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Head and Neck Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sarcoma 1Recurrence 1Precancerous Conditions 1Pharyngeal Neoplasms 1Peritoneal Neoplasms 1Paranasal Sinus Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Laryngeal Neoplasms 1Glioblastoma 1Colonic Neoplasms 1Breast Neoplasms 1Biomarker Change Linked to Breast Cancer 1

Interventions

Peripheral Blood Stem Cell Transplantation 2ruxolitinib 1fludarabine phosphate 1alethine 1Whole-Body Irradiation 1Phenytoin 1Mycophenolic Acid 1Methotrexate 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopy 1Docetaxel 1Cyclosporine 1Celecoxib 1Carboplatin 1CPI-0610 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Precancerous Conditions × Celecoxib × Clear all
NCT00314262 2014-10-24

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Emory University

Phase 1/2 Completed
17 enrolled 7 charts
Other neoplasm

Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡